North America Flow Cytometry Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2023 –2030 |
 Marktgröße (Basisjahr) | USD 2,725.01 Million |
 Marktgröße (Prognosejahr) | USD 6,984.82 Million |
 CAGR |
% |
| Wichtige Marktteilnehmer |
|
North America Flow Cytometry Market, By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales) - Industry Trends and Forecast to 2030.
North America Flow Cytometry Market Analysis and Insights
North America flow cytometry market is driven by the factors such as the increasing prevalence of chronic diseases, growing demand for new technologies in the flow cytometry market, which enhances its demand, as well as increasing investment in research and development, which leads to market growth. Currently, healthcare expenditure has increased across developed and emerging countries which is expected to create a competitive advantage for manufacturers to develop new and innovative flow cytometry markets. However, the high cost of flow cytometry instruments is anticipated to restrain the growth of the North America flow cytometry market.
North America flow cytometry market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an analyst brief, and our team will help you create a revenue impact solution to achieve your desired goal. The scalability and business expansion of the retail units in the developing countries of various regions and partnership with suppliers for the safe distribution of machine and drug products are the major drivers which propelled the demand of the market in the forecast period.
North America flow cytometry market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 12.6% in the forecast period of 2023 to 2030 and is expected to reach USD 6,984.82 Million by 2030 from USD 2,725.01 Million in 2022.
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million |
|
Segments Covered |
By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales) |
|
Countries Covered |
U.S., Canada, and Mexico |
|
Market Players Covered |
Thermo Fisher Scientific Inc. (U.S.), BD(U.S.), Agilent Technologies, Inc. (U.S.), Nexcelom Bioscience LLC (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation(Japan), Miltenyi Biotec (Germany), Coherent Corp. (U.S.), Beckman Coulter, Inc. (A subsidiary of Danaher Corporation) (U.S.), Cytek Biosciences (U.S.), BIOMÉRIEUX (France), Q2 Solutions (a Subsidiary of IQVIA) (U.S.), Cytonome/ST, LLC (U.S.), Merck KGaA (Germany), Sony Biotechnology Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), NanoCellect Biomedical (U.S.), Apogee Flow Systems Ltd. (U.K.), Bay bioscience Co., Ltd. (Japan), Stratedigm, Inc., BioLegend, Inc. (U.S.), NeoGenomics Laboratories(U.S.), Enzo Biochem Inc. (U.S.), Union Biometrica, Inc. (U.S.), BennuBio Inc. (U.S.), ORLFO Technologies(U.S.), Elabscience Biotechnology Inc. (U.S.), Takara Bio Inc. (Japan), among others |
Market Definition
Flow cytometry is a key process for screening cells from a heterologous cell mixture used in cell sorting, counting, protein regeneration, and engineering. The analysis of cell surface and intracellular molecule expression, the characterization and definition of various cell types in a heterogeneous cell population, the evaluation of the purity of isolated subpopulations, and the measurement of cell size and volume are all common uses for flow cytometry. It enables the simultaneous examination of multiple parameters for a single cell. A flow cytometer uses lasers to produce light, which is subsequently dispersed by the sample's cells, recorded by detectors, and converted into signals for analysis and measurement.
The increasing innovations and technologies and rising number of players in the market, and novel product launches are also propelling the growth of the North America flow cytometry market.
North America Flow Cytometry Market Dynamics
Drivers
-
Rising prevalence of chronic diseases
These increasing prevalence and incidences of chronic diseases are likely to drive market growth by focusing on cytometry devices. The increasing incidences of diseases lead to an increase in the North America market as many companies are investing in research and development. This resulted in the enormous lead in demand for advancements to diagnose the disease through quick and accurate techniques.
For instance,
-
In January 2021, according to a World Health Organization report, cancer became the major cause of death in 2020, with 10 million in approximation, where often cases were of breast cancer (2.26 million), lung (2.21 million), colon and rectum (1.93 million); prostate (1.41 million), skin (1.20 million) and stomach (1.09 million)
Therefore, this is raising the demand for North America flow cytometry market.
-
Increasing application of cytometry instruments
Technological developments in cytometry instruments are rising by combining several new techniques to provide high resolution and sensitivity to quantify new entities of cells.
The immunophenotypic analysis is important not only for the initial diagnosis and categorization of acute leukemia, chronic lymphoproliferative disorders, and malignant lymphomas but also for their treatment. Flow cytometry can be used as a sensitive assay to track patients' improvement after chemotherapy or transplantation and detect minimal residual illness (MRD).
For instance,
- In March 2021, Beckman Coulter introduced a CytoFLEX platform that can easily provide multicolor applications, resulting in broadening the technology's laser and color options and causing more technical advancements in this field. The company combined many technologies in CytoFLEX to produce high resolution and sensitivity
- In January 2022, Becton, Dickinson and Company, a North America medical technology company, announced that a study conducted in collaboration with the European Molecular Biology Laboratory (EMBL) and published the new BD innovation in flow cytometry that adds fluorescence imaging and image-based deaccessioning to sort individual cells at exceptionally high speed, based on the visual details of each cell rather than the type or quantity of biomarkers present. The novel method has the potential to revolutionize immunology, cell biology, and genomics research, as well as enable the development of new cell-based therapeutics
Thus, this is expected to act as a driver for the growth of the North America flow cytometry market.
Opportunities
- Increase in adoption of flow cytometry techniques in research and academia
Approval of new technologies provides a new set-off venture in the market. A new mechanism of action is needed to drive the market as it provides innovation in the process by targeting with a different mechanism. It leads to the need for a new product launch in the market.
For instance,
- In March 2021, Beckman Coulter introduced a CytoFLEX platform that can easily provide multicolor applications, resulting in broadening the technology's laser and color options and causing more technical advancements in this field. The company combined many technologies in CytoFLEX to produce high resolution and sensitivity
Hence, flow cytometry provides quick and accurate techniques for diagnosing diseases. The growing demand for advanced diagnostic results for clinical purposes may propel the market's rapid growth.
- Rising healthcare expenditure
The expense of money used by a country on its healthcare and its growth rate over time is inclined by a wide variety of economic and social factors, including the financing arrangements and structure of the organization of the health system. In particular, there is a strong association between the complete income level of a country and how much the population of that country spends on health care.
Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the North America flow cytometry market in the forecast period of 2023-2030.
Restraints/Challenges
- High cost of flow cytometry instruments
Flow cytometers come in a variety of shapes and sizes, although benchtop instruments are the most common. They offer optimal data analysis, the convenience of use, and upgrades and options for various systems, all of which are intended to solve customized separations, cell/particle sorting, exploratory cell analysis, and other issues. All flow cytometers feature three common components – fluids, optics, and electronics/informatics.
Flow cytometers are very expensive especially considering the cost associated with repair and maintenance.
COVID-19 Impact on the North America Flow Cytometry Market
COVID-19 has positively affected the market due to disease diagnosis and research purposes, which raises the demand for flow cytometry during this period.
Recent Development
- In January 2022, Sony Biotechnology, Inc. presented a novel closed cell isolation system CGX10 for use in GMP-compliant cell sorting applications. With the initiative, new growth opportunities were hoped for the company. Such advances in technology will lead to cost-effectiveness, greater accuracy and portability and are likely to create future growth opportunities.
North America Flow Cytometry Market Scope
The North America flow cytometry market is segmented into product, technology, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Product
- Reagents and consumables
- Flow cytometry instruments
- Accessories
- Services
- Software
On the basis of product, the North America flow cytometry market is segmented into flow cytometry instruments, reagents and consumables, software, accessories, and services.
Technology
- Cell-based flow cytometry
- Bead-based flow cytometry
On the basis of technology, the North America flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry.
Application
- Research applications
- Clinical applications
- Industrial applications
On the basis of application, the North America flow cytometry market is segmented into research applications, clinical applications, and industrial applications.
End User
- Pharmaceuticals & biotechnology companies
- Academic & Research institutes
- Hospitals
- Clinical testing laboratories
- Blood bank
- Others
On the basis of end users, the North America flow cytometry market is segmented into academic & research institutes, hospitals, pharmaceutical & biotechnology companies, clinical testing laboratories, blood bank, and others.
Distribution Channel
- Retail sales
- Direct tenders
On the basis of distribution channel, the North America flow cytometry market is segmented into retail sales and direct tenders.
North America Flow Cytometry Market Regional Analysis/Insights
The North America flow cytometry market is analyzed, and market size insights and trends are provided by country, product, technology, application, end user, and distribution channel referenced above.
The U.S. is the major dominating country in the market due to the surging incidence rate of diseases such as cancer and HIV amongst the population in this country, which is boosting the demand for flow cytometry for diagnostic applications. And they are dominating the flow cytometry market in terms of market share and market revenue and will continue to flourish dominance during the forecast period.
The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of North America brands and the challenges faced due to high competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and North America Flow Cytometry Market Share Analysis
The North America flow cytometry market competitive landscape provides details about the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the company's focus on the flow cytometry market.
Some of the major players operating in the flow cytometry market are Thermo Fisher Scientific Inc., BD, Agilent Technologies, Inc., Nexcelom Bioscience LLC, Bio-Rad Laboratories, Inc., Sysmex Corporation, Miltenyi Biotec, Coherent Corp., Beckman Coulter, Inc. (A subsidiary of Danaher Corporation), Cytek Biosciences, bioMérieux SA, Q2 Solutions (a Subsidiary of IQVIA), Cytonome/ST, LLC, Merck KGaA, Sony Biotechnology Inc., Cell Signaling Technology, Inc., NanoCellect Biomedical, Apogee Flow Systems Ltd., Bay bioscience Co., Ltd., Stratedigm, Inc., BioLegend, Inc., NeoGenomics Laboratories, Enzo Biochem Inc., Union Biometrica, Inc., BennuBio Inc., ORLFO Technologies, Elabscience Biotechnology Inc., Takara Bio Inc., among others.
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA FLOW CYTOMETRY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING PREVALENCE OF CHRONIC DISEASES
5.1.2 INCREASING APPLICATION OF CYTOMETRY INSTRUMENTS
5.1.3 INCREASE IN USE OF FLOW CYTOMETRY IN DRUG DISCOVERY
5.1.4 GROWTH IN STEM CELL RESEARCH AND ACQUISITION OF RECOMBINATION OF DNA TECHNOLOGIES
5.2 RESTRAINTS
5.2.1 HIGH COST OF FLOW CYTOMETRY INSTRUMENTS
5.2.2 LIMITATIONS OF FLOW CYTOMETRY
5.2.3 LACK OF SKILLED PROFESSIONALS
5.3 OPPORTUNITIES
5.3.1 INCREASE IN ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN RESEARCH AND ACADEMIA
5.3.2 DEVELOPMENT IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES
5.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
5.3.4 DEVELOPING A PIPELINE OF STEM CELL RESEARCH
5.4 CHALLENGES
5.4.1 DIFFICULTY IN THE DEVELOPMENT AND VALIDATION OF FLOW CYTOMETRY ASSAYS
5.4.2 COMPLEXITIES RELATED TO REAGENT DEVELOPMENT
6 NORTH AMERICA FLOW CYTOMETRY MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 REAGENTS AND CONSUMABLES
6.2.1 DYE
6.2.2 ANTIBODIES
6.2.3 BEADS
6.2.4 OTHERS
6.3 FLOW CYTOMETRY INSTRUMENTS
6.3.1 CELL ANALYZERS
6.3.1.1 CELL ANALYZERS, BY TYPE
6.3.1.1.1 IMAGING FLOW CYTOMETERS
6.3.1.1.2 NON-IMAGING FLOW CYTOMETERS
6.3.1.2 CELL ANALYZERS, BY MODALITY
6.3.1.2.1 BENCHTOP
6.3.1.2.2 STANDALONE
6.3.2 CELL SORTERS
6.3.2.1 BENCHTOP
6.3.2.2 STANDALONE
6.4 ACCESSORIES
6.4.1 FILTERS
6.4.2 DETECTORS
6.4.3 OTHERS
6.5 SERVICES
6.6 SOFTWARE
7 NORTH AMERICA FLOW CYTOMETRY MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 CELL-BASED FLOW CYTOMETRY
7.3 BEAD-BASED FLOW CYTOMETRY
8 NORTH AMERICA FLOW CYTOMETRY MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 RESEARCH APPLICATIONS
8.2.1 CELL CYCLE ANALYSIS
8.2.2 CELL SORTING/SCREENING
8.2.3 CELL TRANSFECTION/VIABILITY
8.2.4 PHARMACEUTICAL AND BIOTECHNOLOGY
8.2.4.1 DRUG DISCOVERY
8.2.4.2 STEM CELL RESEARCH
8.2.4.3 IN VITRO TOXICITY TESTING
8.2.5 IMMUNOLOGY
8.2.6 APOPTOSIS
8.2.7 CELL COUNTING
8.2.8 OTHERS
8.3 CLINICAL APPLICATIONS
8.3.1 HAEMATOLOGY
8.3.2 CANCER
8.3.3 IMMUNODEFICIENCY DISEASES
8.3.4 ORGAN TRANSPLANTATION
8.3.5 OTHER CLINICAL APPLICATION
8.4 INDUSTRIAL APPLICATIONS
9 NORTH AMERICA FLOW CYTOMETRY MARKET, BY END USER
9.1 OVERVIEW
9.2 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES
9.3 ACADEMIC & RESEARCH INSTITUTES
9.4 HOSPITALS
9.5 CLINICAL TESTING LABORATORIES
9.6 BLOOD BANK
9.7 OTHERS
10 NORTH AMERICA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 RETAIL SALES
10.3 DIRECT TENDERS
11 NORTH AMERICA FLOW CYTOMETRY MARKET, BY GEOGRAPHY
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.2 CANADA
11.1.3 MEXICO
12 NORTH AMERICA FLOW CYTOMETRY MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 BD
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENT
14.2.5.1 COLLABORATION
14.3 AGILENT TECHNOLOGIES, INC.
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 SARTORIUS AG
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.5 NEXCELOM BIOSCIENCE LLC
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.5.4 COMPANY SHARE ANALYSIS
14.6 APOGEE FLOW SYSTEMS LTD.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 BAY BIOSCIENCE CO., LTD.
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 BIOMÉRIEUX
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION)
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENTS
14.9.4.1 ACQUISITION
14.9.4.2 PRODUCT LAUNCH
14.1 BENNUBIO INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 BIOLEGEND, INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 BIO-RAD LABORATORIES, INC.
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENT
14.13 CELL SIGNALING TECHNOLOGY, INC.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 CELLKRAFT BIOTECH PVT. LTD
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 CYTEK BIOSCIENCES
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.15.3.1 PRODUCT LAUNCH
14.15.3.2 ACQUISITION
14.16 CYTOBUOY B.V.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 CYTONOME/ST, LLC
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.18 COHERENT CORP.
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.18.4.1 Announcement
14.18.4.2 PRODUCT LAUNCH
14.18.4.3 AWARDS
14.18.5 RECENT DEVELOPMENT
14.19 ELABSCIENCE BIOTECHNOLOGY INC.
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.2 ENZO BIOCHEM INC.
14.20.1 COMPANY SNAPSHOT
14.20.2 REVENUE ANALYSIS
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENT
14.21 IKEDA SCIENTIFIC CO., LTD.
14.21.1 COMPANY SNAPSHOT
14.21.2 PRODUCT PORTFOLIO
14.21.3 RECENT DEVELOPMENT
14.22 MERCK KGAA
14.22.1 COMPANY SNAPSHOT
14.22.2 REVENUE ANALYSIS
14.22.3 PRODUCT PORTFOLIO
14.22.4 RECENT DEVELOPMENT
14.23 MILTENYI BIOTEC
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENT
14.23.3.1 PRODUCT LAUNCH
14.24 NANOCELLECT BIOMEDICAL
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENTS
14.25 NEOGENOMICS LABORATORIES
14.25.1 COMPANY SNAPSHOT
14.25.2 REVENUE ANALYSIS
14.25.3 PRODUCT PORTFOLIO
14.25.4 RECENT DEVELOPMENT
14.26 ON-CHIP BIOTECHNOLOGIES CO., LTD. CORPORATION
14.26.1 COMPANY SNAPSHOT
14.26.2 PRODUCT PORTFOLIO
14.26.3 RECENT DEVELOPMENTS
14.27 ORFLO TECHNOLOGIES
14.27.1 COMPANY SNAPSHOT
14.27.2 PRODUCT PORTFOLIO
14.27.3 RECENT DEVELOPMENT
14.28 Q2 SOLUTION
14.28.1 COMPANY SNAPSHOT
14.28.2 REVENUE ANALYSIS
14.28.3 SERVICE PORTFOLIO
14.28.4 RECENT DEVELOPMENT
14.29 SONY BIOTECHNOLOGY INC.
14.29.1 COMPANY SNAPSHOT
14.29.2 PRODUCT PORTFOLIO
14.29.3 RECENT DEVELOPMENT
14.3 STRATEDIGM, INC
14.30.1 COMPANY SNAPSHOT
14.30.2 PRODUCT PORTFOLIO
14.30.3 RECENT DEVELOPMENT
14.31 SYSMEX CORPORATION
14.31.1 COMPANY SNAPSHOT
14.31.2 REVENUE ANALYSIS
14.31.3 PRODUCT PORTFOLIO
14.31.4 RECENT DEVELOPMENT
14.32 TAKARA BIO INC.
14.32.1 COMPANY SNAPSHOT
14.32.2 REVENUE ANALYSIS
14.32.3 PRODUCT PORTFOLIO
14.32.4 RECENT DEVELOPMENTS
14.33 UNION BIOMETRICA, INC.
14.33.1 COMPANY SNAPSHOT
14.33.2 PRODUCT PORTFOLIO
14.33.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
Tabellenverzeichnis
TABLE 1 NORTH AMERICA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 2 NORTH AMERICA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 NORTH AMERICA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA SERVICES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA SOFTWARE IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA CELL-BASED FLOW CYTOMETRY IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA BEAD-BASED FLOW CYTOMETRY IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA INDUSTRIAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA HOSPITALS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA CLINICAL TESTING LABORATORIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA BLOOD BANK IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA OTHERS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA RETAIL SALES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA DIRECT TENDERS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 NORTH AMERICA FLOW CYTOMETRY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 35 NORTH AMERICA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 36 NORTH AMERICA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 37 NORTH AMERICA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 38 NORTH AMERICA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 39 NORTH AMERICA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 40 NORTH AMERICA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 41 NORTH AMERICA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 42 NORTH AMERICA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 43 NORTH AMERICA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 44 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 45 NORTH AMERICA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 46 NORTH AMERICA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 47 NORTH AMERICA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 48 U.S. FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 49 U.S. REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 50 U.S. FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 51 U.S. CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 52 U.S. CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 53 U.S. CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 54 U.S. ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 55 U.S. FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 56 U.S. FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 57 U.S. RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 58 U.S. PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 59 U.S. CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 60 U.S. FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 61 U.S. FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 62 CANADA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 CANADA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 CANADA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 65 CANADA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 66 CANADA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 67 CANADA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 68 CANADA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 69 CANADA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 70 CANADA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 71 CANADA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 CANADA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 73 CANADA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 74 CANADA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 75 CANADA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 76 MEXICO FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 77 MEXICO REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 78 MEXICO FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 79 MEXICO CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 80 MEXICO CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 81 MEXICO CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 82 MEXICO ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 83 MEXICO FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 84 MEXICO FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 85 MEXICO RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 86 MEXICO PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 87 MEXICO CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 88 MEXICO FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 89 MEXICO FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
Abbildungsverzeichnis
FIGURE 1 NORTH AMERICA FLOW CYTOMETRY MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA FLOW CYTOMETRY MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA FLOW CYTOMETRY MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA FLOW CYTOMETRY MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 NORTH AMERICA FLOW CYTOMETRY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA FLOW CYTOMETRY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA FLOW CYTOMETRY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA FLOW CYTOMETRY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 NORTH AMERICA FLOW CYTOMETRY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA FLOW CYTOMETRY MARKET: SEGMENTATION
FIGURE 11 INCREASING INCIDENCE AND PREVALENCE OF CHRONIC DISEASES ARE EXPECTED TO DRIVE THE NORTH AMERICA FLOW CYTOMETRY MARKET IN THE FORECAST PERIOD
FIGURE 12 THE REAGENTS AND CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA FLOW CYTOMETRY MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA FLOW CYTOMETRY MARKET
FIGURE 14 NORTH AMERICA FLOW CYTOMETRY MARKET: BY PRODUCT, 2022
FIGURE 15 NORTH AMERICA FLOW CYTOMETRY MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA FLOW CYTOMETRY MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA FLOW CYTOMETRY MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 NORTH AMERICA FLOW CYTOMETRY MARKET: BY TECHNOLOGY, 2022
FIGURE 19 NORTH AMERICA FLOW CYTOMETRY MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 20 NORTH AMERICA FLOW CYTOMETRY MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA FLOW CYTOMETRY MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 22 NORTH AMERICA FLOW CYTOMETRY MARKET: BY APPLICATION, 2022
FIGURE 23 NORTH AMERICA FLOW CYTOMETRY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA FLOW CYTOMETRY MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA FLOW CYTOMETRY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 NORTH AMERICA FLOW CYTOMETRY MARKET: BY END USER, 2022
FIGURE 27 NORTH AMERICA FLOW CYTOMETRY MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 NORTH AMERICA FLOW CYTOMETRY MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA FLOW CYTOMETRY MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 NORTH AMERICA FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 NORTH AMERICA FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 NORTH AMERICA FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 NORTH AMERICA FLOW CYTOMETRY MARKET: SNAPSHOT (2022)
FIGURE 35 NORTH AMERICA FLOW CYTOMETRY MARKET: BY COUNTRY (2022)
FIGURE 36 NORTH AMERICA FLOW CYTOMETRY MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 NORTH AMERICA FLOW CYTOMETRY MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 NORTH AMERICA FLOW CYTOMETRY MARKET: PRODUCT (2023-2030)
FIGURE 39 NORTH AMERICA FLOW CYTOMETRY MARKET: COMPANY SHARE 2022 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
